Dysregulation of IL-2 and TGF-β1 has been documented in other long COV studies, with conflicting findings regarding IL-2 levels [12,29] and elevated TGF-β levels in LC patients with pulmonary fibrosis [30]. This evidence concerns the gene TGFB1 and laryngotracheoesophageal cleft.